1. Home
  2. VALN vs TRC Comparison

VALN vs TRC Comparison

Compare VALN & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • TRC
  • Stock Information
  • Founded
  • VALN 2012
  • TRC 1843
  • Country
  • VALN France
  • TRC United States
  • Employees
  • VALN N/A
  • TRC N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • TRC Real Estate
  • Sector
  • VALN Health Care
  • TRC Finance
  • Exchange
  • VALN Nasdaq
  • TRC Nasdaq
  • Market Cap
  • VALN 510.7M
  • TRC 463.5M
  • IPO Year
  • VALN 2021
  • TRC N/A
  • Fundamental
  • Price
  • VALN $6.40
  • TRC $16.69
  • Analyst Decision
  • VALN Strong Buy
  • TRC
  • Analyst Count
  • VALN 3
  • TRC 0
  • Target Price
  • VALN $15.33
  • TRC N/A
  • AVG Volume (30 Days)
  • VALN 83.3K
  • TRC 118.1K
  • Earning Date
  • VALN 05-07-2025
  • TRC 05-08-2025
  • Dividend Yield
  • VALN N/A
  • TRC N/A
  • EPS Growth
  • VALN N/A
  • TRC 298.28
  • EPS
  • VALN N/A
  • TRC 0.08
  • Revenue
  • VALN $201,099,222.00
  • TRC $42,689,000.00
  • Revenue This Year
  • VALN $18.74
  • TRC $0.64
  • Revenue Next Year
  • VALN $29.26
  • TRC N/A
  • P/E Ratio
  • VALN N/A
  • TRC $209.19
  • Revenue Growth
  • VALN 21.64
  • TRC 7.04
  • 52 Week Low
  • VALN $3.62
  • TRC $14.71
  • 52 Week High
  • VALN $9.50
  • TRC $19.82
  • Technical
  • Relative Strength Index (RSI)
  • VALN 48.49
  • TRC 52.32
  • Support Level
  • VALN $6.18
  • TRC $16.09
  • Resistance Level
  • VALN $6.54
  • TRC $16.94
  • Average True Range (ATR)
  • VALN 0.21
  • TRC 0.33
  • MACD
  • VALN 0.01
  • TRC 0.00
  • Stochastic Oscillator
  • VALN 54.35
  • TRC 70.59

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About TRC Tejon Ranch Co

Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.

Share on Social Networks: